169 related articles for article (PubMed ID: 31254226)
21. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
[TBL] [Abstract][Full Text] [Related]
22. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
Tsuruoka S; Kawaguchi A; Nishiki K; Hayasaka T; Fukushima C; Sugimoto K; Saito T; Fujimura A
Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
[TBL] [Abstract][Full Text] [Related]
23. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers.
Thalhammer F; Kletzmayr J; El Menyawi I; Kovarik J; Rosenkranz AR; Traunmüller F; Hörl WH; Burgmann H
Am J Kidney Dis; 1998 Oct; 32(4):642-5. PubMed ID: 9774127
[TBL] [Abstract][Full Text] [Related]
24. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells.
Kobayashi S; Moriya H; Aso K; Ohtake T
Kidney Int; 2003 May; 63(5):1881-7. PubMed ID: 12675867
[TBL] [Abstract][Full Text] [Related]
25. Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers.
Sowinski KM; Mueller BA; Grabe DW; Manley HJ; Frye RF; Bailie GR; Marx MA
Am J Kidney Dis; 2001 Apr; 37(4):766-76. PubMed ID: 11273877
[TBL] [Abstract][Full Text] [Related]
26. Extended reuse of polysulfone hemodialysis membranes using citric acid and heat.
Tonelli M; Dymond C; Gourishankar S; Jindal KK
ASAIO J; 2004; 50(1):98-101. PubMed ID: 14763499
[TBL] [Abstract][Full Text] [Related]
27. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
28. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation.
Kuragano T; Kuno T; Takahashi Y; Yamamoto C; Nagura Y; Takahashi S; Kanmatsuse K
Blood Purif; 2003; 21(2):176-82. PubMed ID: 12601261
[TBL] [Abstract][Full Text] [Related]
30. Levels of cystatin C in low- and high-flux hemodialysis in children with end-stage renal disease.
Fadel FI; Mourad AA; Abdel Rahman AMO; Bazaraa HM; Mohamed MF; El-Lebedy DH; Soliman MM
Pediatr Nephrol; 2017 Sep; 32(9):1603-1609. PubMed ID: 28417217
[TBL] [Abstract][Full Text] [Related]
31. Effects of Vitamin E-Coated versus Conventional Membranes in Chronic Hemodialysis Patients: A Systematic Review and Meta-Analysis.
D'Arrigo G; Baggetta R; Tripepi G; Galli F; Bolignano D
Blood Purif; 2017; 43(1-3):101-122. PubMed ID: 27960188
[TBL] [Abstract][Full Text] [Related]
32. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
[TBL] [Abstract][Full Text] [Related]
33. The effect of vitamin E-bonded polysulfone membrane dialyzer on a new oxidative lipid marker.
Kitamura Y; Kamimura K; Yoshioka N; Hosotani Y; Tsuchida K; Koremoto M; Minakuchi J
J Artif Organs; 2013 Jun; 16(2):206-10. PubMed ID: 23397123
[TBL] [Abstract][Full Text] [Related]
34. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane.
Sirolli V; Ballone E; Di Stante S; Amoroso L; Bonomini M
Int J Artif Organs; 2002 Jun; 25(6):529-37. PubMed ID: 12117292
[TBL] [Abstract][Full Text] [Related]
35. Randomised trial on clinical performances and biocompatibility of four high-flux hemodialyzers in two mode treatments: hemodialysis vs post dilution hemodiafiltration.
Morena M; Creput C; Bouzernidj M; Rodriguez A; Chalabi L; Seigneuric B; Lauret C; Bargnoux AS; Dupuy AM; Cristol JP
Sci Rep; 2019 Dec; 9(1):18265. PubMed ID: 31797880
[TBL] [Abstract][Full Text] [Related]
36. Biocompatibility differences with respect to the dialyzer sterilization method.
Müller TF; Seitz M; Eckle I; Lange H; Kolb G
Nephron; 1998; 78(2):139-42. PubMed ID: 9496728
[TBL] [Abstract][Full Text] [Related]
37. A case of anaphylactoid shock induced by the BS polysulfone hemodialyzer but not by the F8-HPS polysulfone hemodialyzer.
Ohashi N; Yonemura K; Goto T; Suzuki H; Fujigaki Y; Yamamoto T; Hishida A
Clin Nephrol; 2003 Sep; 60(3):214-7. PubMed ID: 14524587
[TBL] [Abstract][Full Text] [Related]
38. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
[TBL] [Abstract][Full Text] [Related]
39. Beta2-microglobulin and low-flux synthetic dialyzers.
Klinkmann H; Buscaroli A; Stefoni S
Artif Organs; 1998 Jul; 22(7):585-90. PubMed ID: 9684696
[TBL] [Abstract][Full Text] [Related]
40. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
